PS
Piper Sandler Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
401
Investar Holding Corp
ISTR
$226M
|
SS
Stephen Scouten
| $22.98 | $27 |
17%
upside
| Overweight |
2 Jul ‘25
2 months ago |
|
402
Bank of Marin Bancorp
BMRC
$405M
|
MC
Matthew Clark
| $25.12 | $25 |
0%
downside
| Neutral |
2 Jul ‘25
2 months ago |
|
403
Blue Owl Capital
OWL
$11.7B
|
CL
Crispin Love
| $18.02 | $23.50 |
30%
upside
| Overweight |
2 Jul ‘25
2 months ago |
|
404
Abacus Life
ABL
$640M
|
CL
Crispin Love
| $6.67 | $10 |
50%
upside
| Overweight |
2 Jul ‘25
2 months ago |
|
|
EFC
405
Ellington Financial
EFC
$1.37B
|
CL
Crispin Love
| $13.70 | $14.50 |
6%
upside
| Overweight |
1 Jul ‘25
2 months ago |
|
406
Mr. Cooper
COOP
$13.8B
|
CL
Crispin Love
| $215.08 | $158 |
27%
downside
| Neutral |
1 Jul ‘25
2 months ago |
|
407
First Busey Corp
BUSE
$2.22B
|
NR
Nathan Race
| $24.91 | $30 |
20%
upside
| Overweight |
1 Jul ‘25
2 months ago |
|
408
Brookfield Asset Management
BAM
$91.8B
|
JB
John Barnidge
| $56.91 | $60 |
5%
upside
| Neutral |
30 Jun ‘25
2 months ago |
|
409
KKR & Co
KKR
$124B
|
JB
John Barnidge
| $138.69 | $150 |
8%
upside
| Overweight |
30 Jun ‘25
2 months ago |
|
410
NovoCure
NVCR
$1.41B
|
JB
Jason Bednar
| $12.60 | $34 |
170%
upside
| Overweight |
27 Jun ‘25
2 months ago |
|
411
CRISPR Therapeutics
CRSP
$4.92B
|
ET
Edward Tenthoff
| $54.10 | $105 |
94%
upside
| Overweight |
27 Jun ‘25
2 months ago |
|
412
Nike
NKE
$110B
|
AA
Anna Andreeva
| $74.15 | $80 |
8%
upside
| Overweight |
27 Jun ‘25
2 months ago |
|
413
Micron Technology
MU
$147B
|
HK
Harsh Kumar
| $131.46 | $165 |
26%
upside
| Overweight |
26 Jun ‘25
2 months ago |
|
414
Context Therapeutics
CNTX
$73.7M
|
BA
Biren Amin
| $0.8214 | $4 |
387%
upside
| Overweight |
26 Jun ‘25
2 months ago |
|
415
Amer Sports
AS
$20.3B
|
AA
Anna Andreeva
| $36.64 | $45 |
23%
upside
| Overweight |
26 Jun ‘25
2 months ago |
|
416
PayPal
PYPL
$65.3B
|
PM
Patrick Moley
| $68.40 | $74 |
8%
upside
| Neutral |
24 Jun ‘25
2 months ago |
|
417
Intapp
INTA
$3.72B
|
PM
Patrick Moley
| $45.34 | $55 |
21%
upside
| Neutral |
24 Jun ‘25
2 months ago |
|
418
Clearwater Analytics
CWAN
$5.97B
|
PM
Patrick Moley
| $20.41 | $27 |
32%
upside
| Overweight |
24 Jun ‘25
2 months ago |
|
419
Molson Coors Class B
TAP
$9.86B
|
ML
Michael Lavery
| $49.88 | $53 |
6%
upside
| Neutral |
23 Jun ‘25
2 months ago |
|
|
VRNA
420
Verona Pharma
VRNA
$9.19B
|
YR
Yasmeen Rahimi
| $106.30 | $160 |
51%
upside
| Overweight |
23 Jun ‘25
2 months ago |
|
421
Couchbase
BASE
$1.35B
|
BB
Brent Bracelin
| $24.44 | $24.50 |
0%
upside
| Neutral |
20 Jun ‘25
2 months ago |
|
422
Sight Sciences
SGHT
$193M
|
AM
Adam Maeder
| $3.69 | $4 |
8%
upside
| Neutral |
18 Jun ‘25
2 months ago |
|
|
HNGE
423
Hinge Health, Inc.
HNGE
$4.47B
|
JT
Jessica Tassan
| $56.97 | $41 |
28%
downside
| Overweight |
16 Jun ‘25
2 months ago |
|
424
Sutro Biopharma
STRO
$83.3M
|
ET
Edward Tenthoff
| $0.9823 | $2 |
104%
upside
| Overweight |
16 Jun ‘25
2 months ago |
|
425
Vertex
VERX
$4.14B
|
BB
Brent Bracelin
| $25.93 | $48 |
85%
upside
| Overweight |
16 Jun ‘25
2 months ago |
|